MingCeler Biotechnology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 5

MingCeler Biotechnology General Information

Description

Provider of biotech laboratory services designed for animal model technology. The company utilizes tetraploid compensation and gene editing technologies, providing biotechnology institutions and pharmaceutical companies with customized mouse models to conduct biological research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 601, Building 13
  • Number. 188 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 400
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 601, Building 13
  • Number. 188 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 400

MingCeler Biotechnology Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MingCeler Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 13-Jul-2026 Completed Generating Revenue
4. Early Stage VC 15-Jul-2024 Completed Generating Revenue
3. Early Stage VC 30-Jun-2023 Completed Generating Revenue
2. Seed Round 13-Sep-2022 $1.45M $1.45M Completed Startup
1. Seed Round Completed Startup
To view MingCeler Biotechnology’s complete valuation and funding history, request access »

MingCeler Biotechnology Patents

MingCeler Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026098510-A1 Construction method for quadruple-resistant animal and use thereof Pending 11-Nov-2024
EP-4144857-A1 Animal preparation method Pending 06-Mar-2020
EP-4144857-A4 Animal preparation method Pending 06-Mar-2020
US-20240263194-A1 Animal preparation method Pending 06-Mar-2020
JP-2023516767-A Animal production method Active 06-Mar-2020 C12N15/8775
To view MingCeler Biotechnology’s complete patent history, request access »

MingCeler Biotechnology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shaanxi Kekong Xietong Venture Capital Growth/Expansion Minority
Elevation China Capital Venture Capital Minority
Guangzhou Jinkong Fund Asset Manager Minority
Entropy Capital Asset Manager Minority
Hunan Shangyi Guanxi Asset Management PE/Buyout Minority
To view MingCeler Biotechnology’s complete investors history, request access »

MingCeler Biotechnology FAQs

  • When was MingCeler Biotechnology founded?

    MingCeler Biotechnology was founded in 2022.

  • Where is MingCeler Biotechnology headquartered?

    MingCeler Biotechnology is headquartered in Guangzhou, China.

  • What industry is MingCeler Biotechnology in?

    MingCeler Biotechnology’s primary industry is Laboratory Services (Healthcare).

  • Is MingCeler Biotechnology a private or public company?

    MingCeler Biotechnology is a Private company.

  • What is MingCeler Biotechnology’s current revenue?

    The current revenue for MingCeler Biotechnology is .

  • How much funding has MingCeler Biotechnology raised over time?

    MingCeler Biotechnology has raised $4.23M.

  • Who are MingCeler Biotechnology’s investors?

    Shaanxi Kekong Xietong Venture Capital, Elevation China Capital, Guangzhou Jinkong Fund, Entropy Capital, and Hunan Shangyi Guanxi Asset Management have invested in MingCeler Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process